This week, the Hang Seng Index rose 0.42% to close at 26126.93 points, having rebounded for four consecutive weeks.

Hong Kong stock IPO market rebounded this week, a total of 4 new shares delivery table, 2 new shares, 1 new share offering, 1 new stock listed.

Among them$minimally invasive robot-B (02252.HK) $Is in the process of offering shares.The offering price of HK $36-43.2 per share and 500 shares per share is expected to close on October 26 and be listed on the Hong Kong Stock Exchange on November 2.

Investors can focus on the largest business operation service provider in China that has submitted the form.$Wanda Business Management (temporary Code) (810130.HK) $The largest mobile voice social platform in China$interesting Maru Group (temporary Code) (810128.HK) $And the "first share of Medical AI" Eagle pupil Technology.

Four companies have delivered forms in the past week:

Wanda business managementIs the largest business operation service provider in China, the company provides business operation services including business management services, property management services and value-added services. It is worth noting that Wanda Business Management, formerly known as Wanda Business, entered the Hong Kong Stock Exchange in December 2014 and became the largest IPO of Hong Kong stocks in that year.

According to the prospectus, Wanda Group is the actual controller of Wanda Business Management, and cornerstone investors hold 21.17% of the equity. Cornerstone investors include Tencent, Ant Technology Group, CITIC Capital, Star Carpenter, United Life Insurance, Country Garden Services Holdings, Jinyi Global (a wholly-owned subsidiary of Country Garden Holdings Hong Kong Development Co., Ltd.), Chow Tai Fook Jewellery Zheng Yutong family and other 22 companies.

The prospectus also shows that Wanda has a betting agreement with investors, and Wanda has agreed to guarantee that the actual net profit of Zhuhai Wanda from 2021 to 2023 will not be less than 5.19 billion yuan, 7.43 billion yuan and 9.46 billion yuan, respectively. If not, Dalian Wanda Commercial and Zhuhai Wansheng will transfer the relevant number of shares at zero consideration or pay cash to investors to compensate investors.

Interest Maru GroupIt is the largest mobile voice social platform and the largest player-centered mobile social platform in China. According to Frost Sullivan, based on the average number of monthly active users in the first half of 2021, the company's flagship mobile app TT Voice had an average of 16.2 million monthly active users in the first half of 2021. In terms of institutional investors, Matrix Partners China sixth Hong Kong holds 11.25 per cent and Tencent holds 3.53 per cent through Image Frame Investment.

Cultural brigade in Greater Bay areaIs a resort property developer with cultural tourism experience, mainly located in Jiangmen and other parts of China where it is considered to have development potential, engaged in a series of cultural tourism business. such as the provision of cultural tourism resort-related services (including hotel services, scenic spot consulting services and scenic spot management services), hotel consulting and management services and travel agency services. It is reported that this is the third failure of China Culture and Travel Group since it first submitted its form on April 17, 2020. This time, it submitted a new prospectus and changed its name to Great Bay area Culture Travel Kangju Co., Ltd. (referred to as "Great Bay area Culture Travel").

VANOV HOLDINGSIs a paper blanket manufacturer with VANOV and Gobear brands. According to Frost Sullivan, the company is one of the top five paper blanket manufacturers in China and the fourth and only paper blanket manufacturer with headquarters in China, with a market share of about 5.8% in terms of 2020 earnings. It is reported that the company failed three times on October 3, 2019, April 24, 2020 and April 15, 2021.

Two new shares have been heard this week.

Eagle pupil Technology (temporary Code) (810117.HK) $It is one of the first companies in China to provide early detection, auxiliary diagnosis and health risk assessment solutions for artificial intelligence retinal image recognition. Retinal imaging, multimodal data analysis and artificial intelligence depth learning algorithm are different from the traditional early detection and auxiliary diagnosis of chronic diseases. Achieve non-invasive, accurate, rapid, effective and scalable detection and diagnosis of chronic diseases in medical institutions and large health providers.

So far, Eagle pupil has 154 patents, patent applications and PCT applications, 24 of which are related to the company's core products, according to the prospectus. If the listing is successful, it is expected to become the "first share of medical AI".

Tian Runyun (temporary Code) (810125.HK) $Tian Runyun is the largest customer contact solution provider deployed in public cloud in China, with a market share of 10.2% in terms of revenue in 2020, according to the Xianshi Consulting report. The company mainly includes three kinds of products: intelligent contact center solution, remote agent solution and ContactBot solution.

This week.$minimally invasive robot-B (02252.HK) $In the hot IPO, as of press time, margin multiple reached 59.73 times. According to the prospectus, the company plans to issue 36.2 million shares, of which 3.62 million shares will be sold publicly and 32.58 million shares will be offered internationally at an offering price of HK $36 to HK $43.20 per share, which is expected to be listed on November 2.

Shanghai minimally invasive Medical Robot (Group) Co., Ltd., founded in 2015, is a leading surgical robot company dedicated to the design, development and commercialization of surgical robots to assist surgeons in complex surgeries. The company is developing the application of Tumai endoscopic surgery robot ("Tumai"), the core product of the company, in urological surgery, and will seek to extend its application to gynaecology, thoracic and general surgery.

According to Frost Sullivan, the company isThe only one in the global industryA company that covers five major and fast-growing surgical specialties, namely endoscopic, orthopaedic, panvascular, transluminal and percutaneous puncture.

This week.Weitai Medical-B (02235.HK) $Listed at a price of HK $30.5, Weitai Medical-B, a medical device company specializing in diabetes management, is currently listed on Atroph, which closed up 3.28 per cent and earned HK $100 in the dark market trading.